Kizzie Houston
Psychiatric/Mental Health · Little Rock, ARNPI 1225620149
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 117 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,228, 2.9 times the $420 reported in 2022.
Across 117 payments — averaging $29.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$768
- AbbVie$468
- Axsome Therapeutics, Inc.$374
- Johnson & Johnson$232
- Vanda Pharmaceuticals Inc.$227
- Otsuka America Pharmaceutical, Inc.$172
- plus $1K from 16 others
What the payments were for
- Food & beverage$3,42999%
- Education$491%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 30 | $768 |
| AbbVie | 16 | $468 |
| Axsome Therapeutics, Inc. | 7 | $374 |
| Johnson & Johnson(2 entities) | 5 | $232 |
| Vanda Pharmaceuticals Inc. | 9 | $227 |
| Otsuka America Pharmaceutical, Inc. | 9 | $172 |
| Neurocrine Biosciences, Inc. | 8 | $160 |
| Corium, LLC | 3 | $151 |
| Braeburn Inc. | 3 | $146 |
| Idorsia Pharmaceuticals US Inc | 4 | $141 |
| Eisai Inc. | 1 | $123 |
| Neurelis, Inc. | 1 | $115 |
| Alkermes, Inc. | 5 | $88 |
| Viiv Healthcare Company | 4 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| EMD Serono, Inc. | 1 | $27 |
| Indivior Inc. | 1 | $25 |
| Exact Sciences | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Merck | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,478 in reported general payments places this provider in the 85th percentile of 359 psychiatric/mental health providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 27 | $53,436 |
| Lurasidone Hcl | 30 | $1,169 |
| Quetiapine Fumarate | 59 | $872 |
| Hydroxyzine Hcl | 49 | $774 |
| Eszopiclone | 31 | $652 |
| Bupropion Hcl | 17 | $517 |
| Hydroxyzine Pamoate | 18 | $511 |
| Duloxetine Hcl | 24 | $510 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 30 | $482 |
| Prazosin Hcl | 38 | $479 |
| Fluvoxamine Maleate | 11 | $387 |
| Trazodone Hcl | 52 | $379 |
| Lamotrigine | 35 | $370 |
| Sertraline Hcl | 46 | $369 |
| Ziprasidone Hcl | 13 | $350 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $468 | $53,43627 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 359 psychiatric/mental health providers in Arkansas.
Other psychiatric/mental health in Little Rock
- Cara MeckfesselLittle Rock$8K
- Stacey HughesLittle Rock$7K
- Michelle HeadLittle Rock$6K
- Sara JonesLittle Rock$6K
- Alicia BarosLittle Rock$6K
- Adrianne FunmakerLittle Rock$5K
- Chloe WardLittle Rock$4K
- Ashley TaylorLittle Rock$4K
- Jennifer RawlsLittle Rock$3K
- Stephanie BohannonFayetteville$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.